News & Trends - Pharmaceuticals
Lundbeck celebrates new workspace focused on collaboration and connectivity

Pharma News: Lundbeck Australia celebrated the company’s return to a newly redesigned workplace in Sydney at an event attended by the Danish Ambassador in Australia.
Lundbeck’s Australian headquarters in Innovation Road, North Ryde, has been transformed with a contemporary new design aimed at maximising collaboration opportunities.
Managing Director Fredrik Kjaer said, “As a result of the COVID-19 pandemic, we have adopted a hybrid office model that allows employees more flexibility on when and where they can work. That in turn has changed the role of the office from being a place to house our workforce to a place primarily for collaboration. It really provides the best of two worlds – structure and sociability on one hand and independence and flexibility on the other.
“In consultation with employees, we’ve incorporated a range of features that have created a welcoming workspace. It’s been important to have different types of spaces such as lounge areas, collaboration zones, breakout spaces and study pods, not just for collaborative work but also for social interaction.
“Lundbeck Australia has been certified a Great Place to Work for the last two years, and just last week our global company was ranked 8th out of 48 pharma companies for our corporate reputation among patient groups who’ve worked with us (PatientView 2020). I’m very proud of how our team has performed and adapted through the challenges presented by COVID-19 and I look forward to continuing to build on our positive and supportive culture.”
The office redesign features enhanced AV connectivity and ergonomic desks. In addition, tighter waste management control and recycling measures have been incorporated in line with Lundbeck’s global commitment on climate action.
Headquartered in Denmark, Lundbeck specialises in researching and treating brain diseases, with approved products in Australia for serious mental illnesses including schizophrenia, bipolar disorder and depression.
“As Australia manages the implications of COVID-19, we feel an even greater sense of purpose in providing the mental health treatments and support that are required. Our mission is to continue to deliver better outcomes for patients and their families through targeted research, investment and high quality education,” Mr Kjaer said.
The Danish Ambassador to Australia, Pernille Kardel and Danish Consul General and Trade Commissioner Carsten Rosendahl joined Lundbeck employees to mark the return to the new office.
Digital & Innovation

Reimagining remote care with Australia’s first virtual hospital
Australia’s first virtual hospital is taking on a new role as a national testbed for advancing the future of patient-facing […]
MoreNews & Trends - MedTech & Diagnostics

Health Minister and Opposition face off at the National Press Club
In a blistering showdown at the National Press Club, Federal Health Minister, Mark Butler, and his Opposition counterpart Senator Anne […]
MoreNews & Trends - Pharmaceuticals

GSK nabs label expansion for RSV vaccine
Coinciding with World Immunisation Week (24-30 April), GSK has secured TGA approval for its respiratory syncytial virus (RSV) vaccine, marking […]
MoreNews & Trends - MedTech & Diagnostics

Low-value imaging linked to high human cost
Imagining has become a cornerstone of modern medicine, for their ability to detect cancers, guide surgeries, and uncover internal injuries […]
More